EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Status epilepticus in POLG disease: a large multinational study

Omar Hikmat, Karin Naess, Martin Engvall, Claus Klingenberg, Magnhild Rasmussen, Eylert Brodtkorb, Elsebet Ostergaard, Irenaeus de Coo, Leticia Pias-Peleteiro, Pirjo Isohanni, Johanna Uusimaa, Kari Majamaa und 10 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12463-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurology, 2024. Verfasst von Omar Hikmat und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway. omar.hikmat@uib.no. Hauptthemen laut MEDLINE: Status Epilepticus, DNA Polymerase gamma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR Cambridge Biomedical Research Centre, Addenbrooke's Charitable Trust, Cambridge University Hospitals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to provide a detailed phenotypic description of status epilepticus (SE) in a large cohort of patients with POLG disease and identify prognostic biomarkers to improve the management of this life-threatening condition. In a multinational, retrospective study with data on patients with POLG disease from seven European countries, we identified those who had SE. The age of SE onset, accompanying clinical, laboratory, imaging and genetic findings were analysed. One hundred and ninety-five patients with genetically confirmed POLG disease were recruited, of whom 67% (130/194) had epilepsy. SE was identified in 77% (97/126), with a median age of SE onset of 7 years. SE was the presenting symptom of the disease in 43% (40/93) of those with SE, while 57% (53/93) developed SE during the disease course. Convulsive SE was reported in 97% (91/94) followed by epilepsia partialis continua in 67% (56/84). Liver impairment 78% (74/95), ataxia 69% (60/87), stroke-like episodes 57% (50/88), were the major comorbidities. In the majority (66%; 57/86) with SE this became refractory or super-refractory. The presence of seizures was associated with significantly higher mortality compared to those without (P ≤ 0.001). The median time from SE debut to death was 5 months. SE is a major clinical feature of POLG disease in early and juvenile to adult-onset disease and can be the presenting feature or arise as part of a multisystem disease. It is associated with high morbidity and mortality, with the majority of patients with SE going on to develop refractory or super-refractory SE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusDNA Polymerase gammaHumansMaleFemaleAdultAdolescentYoung AdultRetrospective StudiesChildEuropeChild, PreschoolMiddle AgedInfantMitochondrial DiseasesAge of Onset

Stichwörter der Autor:innen

POLGEpilepsyMitochondrial diseaseRefractory status epilepticus

Substanzen

DNA Polymerase gammaPOLG protein, human

Autor:innen und Institutionen

  • Department of Paediatrics and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway. omar.hikmat@uib.no.
  • Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway. omar.hikmat@uib.no.
  • European Reference Network for Hereditary Metabolic Disorders, Oslo, Norway. omar.hikmat@uib.no.
  • Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Neuropediatrics, Astrid Lindgren Childrens Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • Wellcome Trust
  • NIHR Cambridge Biomedical Research Centre
  • Addenbrooke's Charitable Trust, Cambridge University Hospitals
  • Helse Vest
  • Medical Research Council
  • Great Ormond Street Hospital Charity
  • Lily Foundation
  • National Institute for Health Research Health Protection Research Unit

Zitieren

APA

Hikmat, O., Naess, K., Engvall, M., Klingenberg, C., Rasmussen, M., Brodtkorb, E., Ostergaard, E., de Coo, I., Pias-Peleteiro, L., Isohanni, P., Uusimaa, J., Majamaa, K., Kärppä, M., Ortigoza-Escobar, J. D., Tangeraas, T., Berland, S., Harrison, E., Biggs, H., Horvath, R., …, & Bindoff, L. A. (2024). Status epilepticus in POLG disease: a large multinational study. Journal of Neurology. https://doi.org/10.1007/s00415-024-12463-5

Vancouver

Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Brodtkorb E, et al. Status epilepticus in POLG disease: a large multinational study. Journal of Neurology. 2024. doi:10.1007/s00415-024-12463-5

BibTeX
@article{Hikmat2024,
  author = {Hikmat, Omar and Naess, Karin and Engvall, Martin and Klingenberg, Claus and Rasmussen, Magnhild and Brodtkorb, Eylert and Ostergaard, Elsebet and de Coo, Irenaeus and Pias-Peleteiro, Leticia and Isohanni, Pirjo and Uusimaa, Johanna and Majamaa, Kari and Kärppä, Mikko and Ortigoza-Escobar, Juan Dario and Tangeraas, Trine and Berland, Siren and Harrison, Emma and Biggs, Heather and Horvath, Rita and Darin, Niklas and Rahman, Shamima and Bindoff, Laurence A},
  title = {Status epilepticus in POLG disease: a large multinational study},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12463-5}
}
Kostenlos starten →